Richard Pfeifer ’73 Joins AVROBIO, Inc. as Director of Preclinical Development

Richard Pfeifer ’73, a Bucknell University alumnus, was recently named the director of preclinical development at AVROBIO, Inc. a clinical-stage biotechnology company that develops gene therapy for rare diseases and cancer.

A board-certified toxicologist, Pfeifer has held previous roles of increasing responsibility at Wyeth Research, Ciba-Geigy Corporation and Shire. He was also an assistant professor of toxicology at Purdue University. He holds a bachelor’s degree in biology from Bucknell, as well as a doctorate in pharmacology from the University of Rochester.

Comments are closed.

Close

Places I've Been

The following links are virtual breadcrumbs marking the 12 most recent pages you have visited in Bucknell.edu. If you want to remember a specific page forever click the pin in the top right corner and we will be sure not to replace it. Close this message.